Immune checkpoint inhibitor-mediated polymyalgia rheumatica versus primary polymyalgia rheumatica: comparison of disease characteristics and treatment requirement
- van der Geest, N. (Invited speaker)
Activity: Talk and presentation › Academic presentation › Academic